ASX Company Announcements

The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange

18 Dec 2014	Cleansing Notice and Appendix 3B
15 Dec 2014	Key Midkine Antibody Patent Granted
15 Dec 2014	Cellmid Capital Raising
11 Dec 2014	Trading Halt
17 Nov 2014	Cellmid Signs Agreement with Zoetis
29 Oct 2014	Appendix 4C - quarterly
10 Oct 2014	Results of Meeting
10 Oct 2014	AGM Presentation by CEO
16 Sep 2014	Cellmid 2014 Annual Report to Shareholders
29 Aug 2014	Appendix 4E and Preliminary Final Report
18 Aug 2014	Cellmid News
29 Jul 2014	Appendix 4C - quarterly
16 Jul 2014	Cellmid Granted UK Patent for Use of Midkine for Hair Growth
15 Jul 2014	Landmark Study - FGF5 Critical Regulator of Human Hair Growth
20 Jun 2014	Quest Diagnostic License Update
19 Jun 2014	Manufacturing Partner Appointed by Cellmid
02 Jun 2014	Change of Director's Interest Notice - Graeme Kaufman
20 May 2014	Notice of ceasing to be a substantial holder
07 May 2014	Key Milestone Completed: Cellmid Lead Antibody Selected for Clinical Trials
30 Apr 2014	Significant New Findings Presented at 3rd Midkine Symposium in Kyoto
28 Apr 2014	Appendix 4C - quarterly
22 Apr 2014	Release of Shares from Voluntary Escrow
15 Apr 2014	Cellmid Signs Mk Tribody Collaboration Agreement
31 Mar 2014	Presentation to the Market
24 Mar 2014	Cellmid News
27 Feb 2014	Appendix 4D and Half Year Report
17 Feb 2014	Cleansing Notice and Appendix 3B
10 Feb 2014	USA RNA/DNA Patent for Surgical Adhesion Allowed
29 Jan 2014	Chinese Distribution Agreement Signed for Hair Loss Products
28 Jan 2014	Appendix 4C - quarterly
06 Jan 2014	Change of Director's Interest Notice - Maria Halasz